Role of Intraoperative Beta Blocker for Morbid Obese Patients Undergoing Laparoscopic Bariatric Surgery
Lecturer of Anesthesia
1 other identifier
interventional
60
1 country
1
Brief Summary
Using esmolol during anesthetic maintenance of laparoscopic bariatric surgery significantly decreases anesthetic, analgesic requirements, postoperative pain, PNV and postoperative hypoxia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Nov 2019
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2019
CompletedFirst Posted
Study publicly available on registry
September 12, 2019
CompletedStudy Start
First participant enrolled
November 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedNovember 25, 2019
November 1, 2019
Same day
September 5, 2019
November 21, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
intraoperative analgesic requirements
amount of narcotics and anesthetics needed
6 months
postoperative analgesic requirements
amount of narcotics needed
6 months
Study Arms (2)
esmolol(breviblock) group
ACTIVE COMPARATORPatients in group E received a loading dose of esmolol(breviblock) 1 mg/kg in 50 ml isotonic saline over 30 minutes before induction of anesthesia, then followed by an infusion of esmolol 10 µg/kg/min until the end of the surgery.
non esmolol group
ACTIVE COMPARATORPatients in group N received 50 ml of isotonic saline over 30 min, followed by an infusion of isotonic saline at same rate of group E till the end of the surgery.
Interventions
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologists (ASA) I - II patients
- age between 18-59 years
- both genders
- body mass index (BMI) \> 45 kg/m2
You may not qualify if:
- Patients with -hepatic
- renal
- cardiac
- respiratory diseases
- patients with a history of drug abuse or who were dependent on opioid drugs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ramymahrose
Cairo, 02, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of anesthesia at faculty of medicine ain shams university
Study Record Dates
First Submitted
September 5, 2019
First Posted
September 12, 2019
Study Start
November 1, 2019
Primary Completion
November 1, 2019
Study Completion
December 1, 2019
Last Updated
November 25, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share
after publication